openPR Logo
Press release

Meningitis Therapeutics Pipeline Review 2018 - P&S Market Research

Meningitis Therapeutics Pipeline Review 2018 - P&S Market

Meningitis is an inflammatory disease which is caused by infection due to bacteria, viruses, parasites, and fungi. It can also occur due to autoimmune diseases and certain medications. The infections due to bacteria first attack the upper respiratory tract and then passes to the brain through blood. Pneumococcal meningitis is caused by Streptococcus pneumonia and meningococcal meningitis occurs due to Neisseria meningitides infection. Viral meningitis is generally caused by enteroviruses that enter the body through the oral cavity and reach the brain. Enteroviruses generally found in saliva, mucus, and feces and transfer from one person to another person through direct contact. Sanofi SA is in the process of developing MenACYW conjugate vaccine for the treatment of meningitis. The University Hospital Inselspital, Berne is in the process of developing daptomycin as a cell wall synthesis inhibitor for the treatment of meningitis. Some of the companies having the pipeline of meningitis include Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd., Sanofi SA, GlaxoSmithKline plc, and others.

Explore Report at: https://www.psmarketresearch.com/market-analysis/meningitis-therapeutics-pipeline-analysis

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningitis Therapeutics Pipeline Review 2018 - P&S Market Research here

News-ID: 974244 • Views:

More Releases from P&S Market Research - Pharmaceuticals

Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments
Psoriasis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Paten …
The study analyzed that the psoriasis therapeutics pipeline comprises approximately 150 drug candidates in different stages of development. Psoriasis is a chronic inflammatory disorder that causes red patches covered with white scales on the skin. It is characterized when a person’s immune system sends defective signals which results in skin cells to grow rapidly. The body does not shed these excess skin cells and pile up on the surface of
Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead
Diabetic Foot Ulcer Therapeutics Pipeline Projects Immense Growth Ahead
The study analysed that the diabetic foot ulcer pipeline comprises of approximately 27 drug candidates in different stages of development. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/diabetic-foot-ulcers-therapeutics-pipeline-analysis Diabetic foot ulcer is a serious complication of diabetes and can be defined as the ulceration in foot along with neuropathy or peripheral artery disease of the lower limb in diabetic patients. Diabetic foot ulcer is categorized into two types namely; neuropathic foot where
Technological Advancements at Cellular and Molecular Level Strengthening the IgA Nephropathy Pipeline
Technological Advancements at Cellular and Molecular Level Strengthening the IgA …
The pipeline involves drug candidates that are being developed using specific targets such as a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BlyS). More than three drug candidates are being developed using subcutaneous route of administration. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/iga-nephropathy-pipeline-analysis The study analyzed that the IgA nephropathy therapeutics pipeline comprises of 24 drug candidates in different stages of development. The report also includes epidemiology forecast for IgA Nephropathy for the
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF. Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market As per the findings of research, it

All 5 Releases


More Releases for Meningitis

Meningitis Treatment Market: Comprehensive Analysis and Future Outlook
The meningitis treatment market was valued at approximately USD 4.5 billion in 2023 and is anticipated to reach USD 7.2 billion by 2033, growing at a CAGR of 4.8% from 2024 to 2033. The global meningitis treatment market represents a critical segment within the broader infectious disease therapeutics landscape. Meningitis, characterized by inflammation of the protective membranes covering the brain and spinal cord, remains a significant medical emergency requiring immediate intervention.
[Latest] Meningitis Diagnostic Testing Market : An Overview
The ""Meningitis Diagnostic Testing Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Meningitis Diagnostic Testing Market, 2024-2031 Verified Market Research's most recent report, ""Meningitis Diagnostic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,""
Meningitis - Drug Pipeline Landscape, 2022
Meningitis is an inflammation of the fluid and membranes (meninges) surrounding your brain and spinal cord. Meningitis can be caused by a bacterial, fungal or viral infection. Viral infections are the most common cause of meningitis, followed by bacterial infections and, rarely, fungal and parasitic infections. Less common causes of meningitis include autoimmune disorder, cancer medicines. Meningitis symptoms include confusion, fever, headache numbness, sensitivity to light, stiff neck, upset stomach or vomiting,
Meningitis Diagnostic Testing Market Trends and Report 2025
The study on the meningitis diagnostic testing market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The authors have adopted and implemented wide range of industry-validated tools use for primary and secondary research. The study analysts have leveraged cutting-edge and well-established decision science methods to identify trends and distil useful insights from complex data. Some of the methods used for evaluating the strategic landscape of
Meningitis - Drug Pipeline Landscape, 2022 | Global Insight Services
Meningitis is an inflammation of the fluid and membranes (meninges) surrounding your brain and spinal cord. Meningitis can be caused by a bacterial, fungal or viral infection. Viral infections are the most common cause of meningitis, followed by bacterial infections and, rarely, fungal and parasitic infections. Less common causes of meningitis include autoimmune disorder, cancer medicines. Meningitis symptoms include confusion, fever, headache numbness, sensitivity to light, stiff neck, upset stomach
Global Meningitis Vaccine Market Analysis |Outlook to 2025
This report at InForGrowth presents the worldwide Meningitis Vaccine market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Download for Sample copy of this report at https://www.inforgrowth.com/samplerequest/r/16184/global-meningitis-vaccine-market-insights-fore The